• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AMO UPPSALA AB UNK_OVD_HEALON PRO; AID, SURGICAL, VISCOELASTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AMO UPPSALA AB UNK_OVD_HEALON PRO; AID, SURGICAL, VISCOELASTIC Back to Search Results
Model Number TH85ML
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Glaucoma (1875); Hyphema (1911); Intraocular Pressure Increased (1937)
Event Type  Injury  
Manufacturer Narrative
Section a2: mean age 71.6 +- 10.5.Section a3: 14 female and 13 male patients.Sections a4, a5: information unknown/not provided.Section b3: date of event: exact dates not provided.Article published date is january 10, 2023.The study was conducted for surgeries performed between december 2016 and december 2020.Section d4: catalog number: complete catalog number is unknown, as the lot number was not provided.Section d4: lot number: unknown, information not provided.Section d4: expiration date: unknown, as the lot number was not provided.Section d4: udi number: unknown, as the lot number was not provided.Section d6a - implant date: not applicable.The healon is not an implantable device.Section d6b - explant date: not applicable.The healon is not an implantable device; therefore, not explanted.Section e1 - email and phone number not provided section h3 - other (81): the healon was not returned for evaluation.Therefore, a failure analysis of the complaint device could not be completed.A review of the device history record, complaint trending, and risk documentation for this device will be performed.Upon completion of the review and possible product return and evaluation, if there is any further relevant information a supplemental medwatch will be filed.Section h4: device manufacture date: unknown, as the lot number was not provided.Citation: okada, n.; hirooka, k.; onoe, h.; okumichi, h.; kiuchi, y.Comparison of mid-term outcomes between microhook ab interno trabeculotomy and goniotomy with the kahook dual blade.J.Clin.Med.2023, 12, 558.Https://doi.Org/10.3390/jcm12020558.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Event Description
The following article was received based on a literature review: article: comparison of mid-term outcomes between microhook ab interno trabeculotomy and goniotomy with the kahook dual blade a retrospective study was done to compare the mid-term surgical outcomes between patients who underwent phacoemulsification in primary open-angle glaucoma (poag) and exfoliation glaucoma combined with microhook ab interno trabeculotomy (¿lot) and goniotomy with the kahook dual blade (kdb).A total of 54 eyes underwent either microhook ab interno trabeculotomy (¿lot) (n=27 eyes) or goniotomy with the kahook dual blade (n=27 eyes).Phacoemulsification in all eyes was performed using the signature pro (johnson & johnson) and the intraocular lens (iol) implanted were either the pcb00v (johnson & johnson) or the xy1 (hoya) iol.In order to increase the visuality of schlemm¿s canal after the cataract surgery, sufficient sodium hyaluronate (healon; johnson & johnson vision) was added to the anterior chamber.Postoperative complications include transient iop elevation (n=5) and hyphema with niveau (n=4).The hyphema disappeared within 2 weeks in all of the cases.It was reported that additional surgery was required in 3 eyes in the kdb-phaco group, with one surgery for exfoliation glaucoma and the other two surgeries for primary open angle glaucoma (poag) all of which were due to inadequate iop reduction (>21 mmhg).No further details were provided.Separate reports will be submitted for the other two johnson & johnson devices reported.
 
Manufacturer Narrative
Correction: the following information was inadvertently not included in the initial report section e1: phone number (b)(6) and fax number fax: (b)(6) email address: (b)(6).Contact first/given name: (b)(6).Contact last name: (b)(6).
 
Manufacturer Narrative
Corrected data: based on a further review of the information received, the code 1875 (glaucoma) was removed and the code 4625 (additional surgery) was added.All pertinent information available to johnson and johnson surgical vision, inc.Has been submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK_OVD_HEALON PRO
Type of Device
AID, SURGICAL, VISCOELASTIC
Manufacturer (Section D)
AMO UPPSALA AB
rapsgatan 7
uppsala, uppsala län 754 5 0
SW  754 50
Manufacturer Contact
somyata nagpal
31 technology drive
irvine, CA 92618
7142478552
MDR Report Key17463664
MDR Text Key320472442
Report Number3012236936-2023-01916
Device Sequence Number1
Product Code LZP
UDI-Public(01)(10)UNKNOWN
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P810031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 11/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/04/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTH85ML
Device Catalogue NumberUNK-OVD_HEALON PRO
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received10/27/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-